ORTHOBOND
Orthobond Corp. develops surface modification technology that can be applied to synthetic materials to produce biological responses. It offers a technology based on self-assembled monolayers of phosphonate (SAMP); and osteoconductive self-assembled monolayer of phosphonate surface modification that elicits a biological response on inorganic implants without the use of a biologic. The company also provides bioresistant technology to address the need of tissue integration into permanent implants; and AI-SAMP anti-infective technology that helps in preventing a range of orthopedic infections by killing bacteria as they contact the pin surface and preventing biofilm formation, pre and post-operatively. Orthobond Corp. was founded in 2003 and is based in North Brunswick, New Jersey.
ORTHOBOND
Industry:
Biotechnology Health Care Medical Device
Founded:
2004-01-01
Address:
North Brunswick, New Jersey, United States
Country:
United States
Website Url:
http://www.orthobond.com
Total Employee:
1+
Status:
Active
Contact:
732-729-6235
Total Funding:
2.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Global Site Tag Euro Organization Schema Google Maps AJAX Libraries API
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Kintai Therapeutics
Kintai is a biotechnology company that advancing precision therapeutics based on enteric signaling networks in the human body.
Current Advisors List
Advisor
Current Employees Featured
Gregory Lutz President and CEO @ Orthobond
President and CEO
Founder
Official Site Inspections
http://www.orthobond.com
- Host name: myshopify.com
- IP address: 23.227.38.65
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Orthobond"
Orthobond - Crunchbase Company Profile & Funding
Orthobond Corp. develops surface modification technology that can be applied to synthetic materials to produce biological responses. It offers a technology based on self-assembled monolayers of phosphonate (SAMP); and osteoconductive …See details»
Orthobond Antimicrobial Nanosurface Technology
Orthobond’s technology creates a covalently bound nanosurface that is designed to kill bacteria, viruses and fungi, yet is safe for human contact. Our first products will be a series of antimicrobial medical device surface treatments designed to …See details»
Orthobond - Org Chart, Teams, Culture & Jobs - The Org
View Orthobond's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. Explore. Iterate. Vision. Log in. Sign up. …See details»
Orthobond Company Profile 2024: Valuation, Funding & Investors
Orthobond General Information Description. Developer of antimicrobial surface treatments designed to offer antimicrobial nanosurfaces for medical devices. The company's antimicrobial …See details»
About Othobond Antimicrobial technology nanosurface …
Orthobond’s antimicrobial nanosurface technology works by killing unwanted microbes on the surfaces of medical devices, thereby reducing the risk for microbial contamination. Our …See details»
Orthobond Company Profile - Office Locations, Competitors
Orthobond has 5 employees across 2 locations and $2.1 m in total funding,. See insights on Orthobond including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Orthobond Expands its Board of Directors with Appointment of …
PRINCETON, N.J., July 10, 2024--Orthobond Corporation, a leader in covalently-bound antibacterial surface technologies with broad applications in the medical device industry, today …See details»
Orthobond Company Profile: Overview and Full News Analysis
Orthobond focuses on the Medical Devices sector. Explore the world of Startups and Venture Investing at OurCrowd.See details»
Orthobond - Products, Competitors, Financials, Employees, …
Orthobond Appoints George Landau as EVP, Business Development and Commercialization. Oct 31, 2024. October 30, 2024 George Landau PRINCETON, N.J.–( BUSINESS WIRE )– …See details»
Orthobond - Funding, Financials, Valuation & Investors - Crunchbase
Orthobond is a biotechnology company that is focused on improving the performance and safety of implantable medical devices. Search Crunchbase. ... How much funding has this …See details»
Orthobond - Contacts, Employees, Board Members, Advisors
Orthobond is a biotechnology company that is focused on improving the performance and safety of implantable medical devices.See details»
Orthobond Technology - orthobond.com
In addition, Orthobond’s technology is supported by a substantial suite of biocompatibility and safety data and utilizes a molecule that has a history of safe use in humans. Orthobond’s …See details»
Orthobond - Updates, News, Events, Signals & Triggers
Organization. Orthobond . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Growth Insight Details. Powered by AI . ... Orthobond …See details»
Orthobond Delivers Its First OSTAGUARD™ Coated ... - Business Wire
3 days ago Orthobond Corporation is a surface technology company that has developed proprietary antibacterial surfaces with broad applications in multiple industries such as medical …See details»
The Orthobond Surface Design Lab - orthobond.com
Nov 5, 2024 When Orthobond CEO David Nichols is asked which historical figure he admires most, his answer is Alexander Fleming. “More lives were probably saved in the 20 th century …See details»
FDA Clears 99.99% Zero Bacteria Implant Coating
Jun 4, 2024 With this latest FDA decision, the era of, literally, 99.99% zero bacterial contamination on any musculoskeletal implant is beginning. This new technology, which …See details»
Orthobond - Crunchbase
Orthobond is a biotechnology company that is focused on improving the performance and safety of implantable medical devices. Search Crunchbase Start Free TrialSee details»
Orthobond - Kineticos Life Sciences
Orthobond has pioneered a groundbreaking method to permanently alter the surfaces of metal and polymer medical devices to destroy bacteria that contact these surfaces during implant …See details»
Collaboration - orthobond.com
Orthobond is currently engaged in multiple collaborations with leading industry, academic, and clinical research groups. We are actively building relationships with a select group of global …See details»
Ostaguard - orthobond.com
Our proprietary Ostaguard™antibacterial surface treatment is the first of its kind to be granted U.S. Food and Drug Administration (FDA) De Novo classification. With an initial application in …See details»